ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday,
ORIC® Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Chacko, M.D., chief executive officer, will present a company overview at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 11:15 a.m. PT. A live webcast of the company presentation will be available through the investor section of the company’s website at A replay of the webcast will be available for 90 days following the event.
Actio Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Actio Biosciences is leveraging advances in precision medicine to develop new therapeutics that target shared genetics in rare and common diseases—bringing meaningful medicines from one to many. Applying its expertise in genetics,
Hosted on MSN20h
ResMed Inc. Reports Change in Beneficial OwnershipResmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) has provided an update. ResMed Inc.
Shares of ResMed Inc. RMD advanced 1.40% to $231.67 Friday, on what proved to be an all-around positive trading session for ...
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) just unveiled an update.
ResMed launches AirSense 11, to advance digital health in sleep apnoea for Indians: Our Bureau, Bengaluru Monday, January 6, 2025, 17:30 Hrs [IST] ResMed, the world’s leading he ...
Shares of ResMed Inc. RMD dropped 0.09% to $228.48 Thursday, on what proved to be an all-around rough trading session for the ...
ResMed Inc. RMD has witnessed strong momentum in the past year. Shares of the company have risen 37.8% compared with 10.7% growth of the industry during the same time frame. The S&P 500 composite ...
Chip stocks advanced, led by Broadcom ( AVGO) after UBS analysts raised their price target for the stock, citing the ...
ResMed actually specializes in ventilators, for example against sleep apnoea. Now comes the first end customer product for ...
ResMed (NYSE:RMD) has had a rough month with its share price down 5.8%. However, stock prices are usually driven by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback